Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Lung cancer is the leading cause of cancer death worldwide. Therefore, advances in the diagnosis and treatment of the disease are urgently needed. miRNAs are a family of small, noncoding RNAs that regulate gene expression at the transcriptional level. miRNAs have been reported to be deregulated and to play a critical role in different types of cancer, including lung cancer. Thus, miRNA profiling in lung cancer patients has become the core of several investigations. To this end, the development of a multitude of platforms for miRNA profiling analysis has been essential. This article focuses on the different technologies available for assessing miRNAs and the most important results obtained to date in lung cancer.

Original publication

DOI

10.2217/fon.14.93

Type

Journal article

Journal

Future oncology (London, England)

Publication Date

11/2014

Volume

10

Pages

2279 - 2292

Addresses

Molecular Oncology Laboratory, Fundación para la Investigación del Hospital General Universitario de Valencia, Av. Tres Cruces s/n, 46014 Valencia, Spain.

Keywords

Humans, Lung Neoplasms, MicroRNAs, Genetic Testing, Biomarkers, Tumor